InsidersTradesSigma
Dawnrays Pharmaceutical (Holdings) Ltd.: management transactions · Hong Kong · HKEX
HKEX:dawnrays-pharmaceutical-holdings-ltdHK·HKEXMcap 1.7Bn€Healthcare
Browse the full insider trade history of Dawnrays Pharmaceutical (Holdings) Ltd., a listed issuer based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. Operating in the Healthcare sector, Dawnrays Pharmaceutical (Holdings) Ltd. has logged 15 insider filings. Market capitalisation: €1.7bn. The latest transaction was filed on 15 May 2026 — Other. Among the most active insiders: Hung Yung Lai. Every trade is free.
15
Insider Decl.
0
Thresholds
€69,859
14 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.12 €
Analyst consensus
Income statement
Revenue1.23 Bn€
Gross profit612.2 M€50% margin
Net income214.0 M€17.4% margin
Valuation
PER (trailing)7.0x
P/Book0.4x
Beta0.27
Balance sheet & cash
Market cap1.68 Bn€
Total debt77.5 M€
Free Cash Flow236.0 M€
Debt / Equity2%
Profitability & ownership
ROE6.3%
ROA3.5%
% insiders67.6%
% institutions11.2%
Last declaration on 15 May 2026
Declarations15 total
Executives●Purchase7HKEX
€4,45336,000 shares@ €0.12370.0003% mcap12.7% of flow
ShareXHKG
HKEX:DA20260514E00650·
Ideal exit: 8 Feb 2027 (T+270)
Executives●Purchase7HKEX
€4,45336,000 shares@ €0.12370.0003% mcap12.7% of flow
ShareXHKG
HKEX:DA20260514E00647·
Ideal exit: 8 Feb 2027 (T+270)
Executives●Purchase8HKEX
€6,50752,000 shares@ €0.12510.0004% mcap18.6% of flow
ShareXHKG
HKEX:DA20260508E00513·
Ideal exit: 1 Feb 2027 (T+270)
Executives●Purchase8HKEX
€6,50752,000 shares@ €0.12510.0004% mcap18.6% of flow
ShareXHKG
HKEX:DA20260508E00494·
Ideal exit: 1 Feb 2027 (T+270)
Executives●Purchase6HKEX
€9748,000 shares@ €0.12180.0001% mcap2.8% of flow
ShareXHKG
HKEX:DA20260423E00021·
Ideal exit: 16 Jan 2027 (T+270)
Executives●Purchase6HKEX
€9748,000 shares@ €0.12180.0001% mcap2.8% of flow
ShareXHKG
HKEX:DA20260423E00020·
Ideal exit: 16 Jan 2027 (T+270)
Executives●Purchase8HKEX
€5,32844,000 shares@ €0.12110.0003% mcap15.3% of flow
ShareXHKG
HKEX:DA20260416E00055·
Ideal exit: 10 Jan 2027 (T+270)
Executives●Purchase8HKEX
€5,32844,000 shares@ €0.12110.0003% mcap15.3% of flow
ShareXHKG
HKEX:DA20260416E00051·
Ideal exit: 10 Jan 2027 (T+270)
Executives●Purchase7HKEX
€2,45320,000 shares@ €0.12260.0001% mcap7.0% of flow
ShareXHKG
HKEX:DA20260415E00002·
Ideal exit: 8 Jan 2027 (T+270)
Executives●Purchase7HKEX
€2,45320,000 shares@ €0.12260.0001% mcap7.0% of flow
ShareXHKG
HKEX:DA20260415E00001·
Ideal exit: 8 Jan 2027 (T+270)
Executives●Purchase7HKEX
€5,01940,000 shares@ €0.12550.0003% mcap14.4% of flow
ShareXHKG
HKEX:DA20260403E00005·
Ideal exit: 27 Dec 2026 (T+270)
Executives●Purchase7HKEX
€5,01940,000 shares@ €0.12550.0003% mcap14.4% of flow
ShareXHKG
HKEX:DA20260403E00004·
Ideal exit: 27 Dec 2026 (T+270)
Executives●Purchase9HKEX
€10,19584,000 shares@ €0.12140.0006% mcap29.2% of flow
ShareXHKG
HKEX:DA20260331E00419·
Ideal exit: 25 Dec 2026 (T+270)
Executives●Purchase9HKEX
€10,19584,000 shares@ €0.12140.0006% mcap29.2% of flow
ShareXHKG
HKEX:DA20260331E00415·
Ideal exit: 25 Dec 2026 (T+270)
15 of 15 declarations